Business

Novartis Keeps CEO Pay Steady, But Incoming Chairman Pay Drops

Novartis (NOVN.VX) kept pay for its Chief Executive Joe Jimenez steady, after cutting it last year before a Swiss vote to force companies to accept shareholder limits on executive rewards.